FDA Plans to Formally Kick Off SAE Consortium in a Few Weeks; Seeks Participants | GenomeWeb
NEW YORK (GenomeWeb News) – The US Food and Drug Administration plans to formally launch its newly formed Serious Adverse Events Consortium in “the next couple of weeks,” an FDA official told GenomeWeb News today.
As GenomeWeb News reported this morning, the FDA is forming a consortium of drugmakers and academic research groups that aims to study how genetic biomarkers contribute to serious adverse events.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.